#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition


Navidea strengthens leadership team

Staff writer |
Dublin, Oh., USA - January 6, 2015, Dublin, Oh., USA - Navidea Biopharmaceuticals, a biopharmaceutical company, appointed Thomas J. Klima as senior vice president and chief commercial officer and Michael Tomblyn as executive medical director.

Mr. Klima joins Navidea having held numerous commercial leadership positions, including Head of Sales for oncology company, Algeta (recently acquired by Bayer AG) and Senior Director of Marketing at Dendreon Corporation.

Mr. Klima also led various U.S. and global commercial efforts at Eli Lilly, including U.S. Marketing for the Cymbalta Brand Team. He has a B.A. degree in Business Administration and Marketing from Western State College.

Dr. Tomblyn served as Senior Medical Director of Bayer Healthcare/Algeta focusing on targeted-radiation therapies.

Prior to this he was Assistant Member and Director of Clinical Research, Department of Radiation Oncology, at H. Lee Moffitt Cancer Center and Assistant Professor, Department of Oncologic Science, at University of South Florida.


What to read next

FluoroPharma Medical appoints Thomas Tulip as CEO
Simon Brebner named CCO at Abu Dhabi Terminals
Richard Payette appointed president & CEO, Manulife Quebec